Cargando…

Hepatic peroxisome proliferator-activated receptor γ and α-mRNA expression in HCV-infected adults is decreased by HIV co-infection and is also affected by ethnicity

OBJECTIVE: To determine peroxisome proliferator activated receptor α and γ mRNA expression in liver tissue of hepatitis C virus-infected patients with and without human immunodeficiency virus and its possible contribution to an acceleration of liver disease progression. METHODS: We measured peroxiso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shores, Nathan J, Mendes-Corrêa, Maria Cássia, Maida, Ivana, Turner, JoLyn, High, Kevin P, Babudieri, Sergio, Núñez, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2015
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676314/ https://www.ncbi.nlm.nih.gov/pubmed/26735218 http://dx.doi.org/10.6061/clinics/2015(12)05

Ejemplares similares

Peroxisome Proliferator-Activated Receptors in HCV-Related Infection
por: Dharancy, Sébastien, et al.
Publicado: (2009)

Quick diagnosis, staging, and treatment of HCV infection among people living in prison: Opinion expert panel
por: Fiore, Vito, et al.
Publicado: (2022)

Viral Hepatitis C New Microelimination Pathways Objective: Psychiatric Communities HCV Free
por: Fiore, Vito, et al.
Publicado: (2022)

Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations
por: Fiore, Vito, et al.
Publicado: (2023)

HCV Core Residues Critical for Infectivity Are Also Involved in Core-NS5A Complex Formation
por: Gawlik, Katarzyna, et al.
Publicado: (2014)

Peroxisome Proliferator-Activated Receptor-γ-Mediated Polarization of Macrophages in Leishmania Infection
por: Chan, Marion M., et al.
Publicado: (2012)

Strong correlation by ultrasonography of hepatomegaly and the presence of co-infection in HIV/HCV cirrhotic patients
por: Vezozzo, Denise Cerqueira Paranaguá, et al.
Publicado: (2013)

Peroxisome proliferator-activated receptor-γ as the gatekeeper of tight junction in Clostridioides difficile infection
por: Lai, Yi-Hsin, et al.
Publicado: (2022)

The Role of Peroxisome Proliferator-Activated Receptor γ in Immune Responses to Enteroaggregative Escherichia coli Infection
por: Philipson, Casandra W., et al.
Publicado: (2013)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Intravenous drug use – an independent predictor for HCV genotypes 3 and 4 infection among HIV/HCV co-infected patients
por: Salemovic, Dubravka, et al.
Publicado: (2017)

Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes
por: De Vito, Andrea, et al.
Publicado: (2021)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020)

Peroxisome Proliferator-Activator Receptor γ: A Link between Macrophage CD36 and Inflammation in Malaria Infection
por: Ren, Yi
Publicado: (2012)

Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
por: Ferrari, Silvia Martina, et al.
Publicado: (2015)

Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b
por: Alkhatib, Mohammad, et al.
Publicado: (2021)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users
por: Flynn, Jacqueline K, et al.
Publicado: (2014)

Safety and efficacy of molnupiravir in SARS‐CoV‐2‐infected patients: A real‐life experience
por: De Vito, Andrea, et al.
Publicado: (2022)

LncRNAs in HCV Infection and HCV-Related Liver Disease
por: Unfried, Juan P., et al.
Publicado: (2020)

Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients
por: Kushner, Lauren E., et al.
Publicado: (2013)

Erratum to “Barriers to treatment of hepatitis C in HIV/HCV coinfected adults in Brazil” [Braz. J. Infect. Dis. 14 (3) (2010) 237–241]
por: Mendes-Corrêa, Maria Cássia, et al.
Publicado: (2016)

Lipid Metabolism and HCV Infection
por: Targett-Adams, Paul, et al.
Publicado: (2010)

Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Inflammation
por: Ohshima, Kousei, et al.
Publicado: (2012)

Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis
por: Liu, Huang-Jun, et al.
Publicado: (2016)

Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases
por: Zhang, Su, et al.
Publicado: (2015)

Effect of peroxisome proliferator-activated receptor γ on inflammatory markers
por: Khazaei, Majid
Publicado: (2015)

The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
por: Li, Jingjing, et al.
Publicado: (2021)

Oligosymptomatic COVID-19 infection also needs to be recognised
por: Jolobe, Oscar M.P.
Publicado: (2021)

HTLV-1 Is Also a Sexually Transmitted Infection
por: Martel, Mariana, et al.
Publicado: (2022)

Is type III prostatitis also associated with bacterial infection?
por: Song, Wei-Jie, et al.
Publicado: (2023)

The essential role of fungal peroxisomes in plant infection
por: Falter, Christian, et al.
Publicado: (2022)

How are HCV-infected patients being identified in Brazil: a multicenter study
por: Portari-Filho, Luiz H., et al.
Publicado: (2019)

HCV-Specific T Cell Responses During and After Chronic HCV Infection
por: Luxenburger, Hendrik, et al.
Publicado: (2018)

Molecular surveillance of HCV mono-infection and HCV-HBV co-infection in symptomatic population at Hyderabad, Pakistan
por: Patoli, Bushra B, et al.
Publicado: (2018)

Compartmentalization of Resistance-Associated Substitutions in HIV/HCV-Infected Patients: Possible Correlation with Infecting HCV Genotype
por: Morsica, Giulia, et al.
Publicado: (2021)

Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Suppresses Inflammation and Bacterial Clearance during Influenza-Bacterial Super-Infection
por: Gopal, Radha, et al.
Publicado: (2019)

Interferon-α Improves Phosphoantigen-Induced Vγ9Vδ2 T-Cells Interferon-γ Production during Chronic HCV Infection
por: Cimini, Eleonora, et al.
Publicado: (2012)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

Association of APOL1 variants with mild kidney disease in first-degree relatives of African American patients with non-diabetic end stage renal disease
por: Freedman, Barry I., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ak878n6jj1m0htkp1in5q0fepk